Mission Creek Capital Partners’s Pfizer PFE Stock Holding History

Mission Creek Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	22,248 +6,746	+44%	+$176K	0.06%	171
2026 Q1	$223K	Buy	+15,502	New	+$413K	0.04%	209
2025 Q1	–	Sell	-10,183	Closed	-$69.8K	–	219
2024 Q4	$69.8K	Buy	+10,183	New	+$276K	0.02%	231
2024 Q2	–	Sell	-9,997	Closed	-$277K	–	224
2024 Q1	$277K	Buy	+9,997	New	+$277K	0.07%	209
2023 Q2	–	Sell	-6,013	Closed	-$245K	–	236
2023 Q1	$245K	Buy	6,013 +28	+0.5%	+$1.21K	0.08%	198
2022 Q4	$307K	Sell	5,985 -157	-3%	-$7.53K	0.11%	183
2022 Q3	$269K	Hold	6,142	–	–	0.1%	179
2022 Q2	$322K	Hold	6,142	–	–	0.11%	177
2022 Q1	$318K	Sell	6,142 -1,112	-15%	-$57.7K	0.08%	194
2021 Q4	$428K	Hold	7,254	–	–	0.09%	186
2021 Q3	$312K	Hold	7,254	–	–	0.06%	209
2021 Q2	$284K	Sell	7,254 -739	-9%	-$28.7K	0.05%	204
2021 Q1	$290K	Sell	7,993 -113	-1%	-$4.01K	0.04%	199
2020 Q4	$298K	Sell	8,106 -301	-4%	-$11K	0.09%	177
2020 Q3	$293K	Sell	8,407 -174	-2%	-$6.1K	0.12%	174
2020 Q2	$266K	Buy	8,581 +16	+0.2%	+$544	0.14%	145
2020 Q1	$265K	Hold	8,565	–	–	0.14%	138
2019 Q4	$318K	Buy	+8,565	New	+$305K	0.15%	150

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mission Creek Capital Partners's PFE Position: Q2 2026 in Review

Mission Creek Capital Partners increased its Pfizer (PFE) stake by 44% in Q2 2026, buying an estimated $176K and bringing the position to 22,248 shares worth $355K. The position accounts for 0.06% of the portfolio, ranked #171.

Mission Creek Capital Partners first reported a position in PFE in Q4 2019 and has held it in 18 quarters since. The position peaked at $428K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Mission Creek Capital Partners held 22,248 shares of Pfizer worth $355K as of Q2 2026.
Mission Creek Capital Partners bought 6,746 Pfizer shares in Q2 2026, an estimated $176K.
Pfizer made up 0.06% of Mission Creek Capital Partners's portfolio in Q2 2026, its #171 holding.
Mission Creek Capital Partners first reported a position in Pfizer in Q4 2019 and has held it in 18 quarters since.
Mission Creek Capital Partners's Pfizer position peaked at $428K in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.